Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period

Pharmacology Biochemistry and Behavior

Volumn 79, Issue 4, 2004, Pages 723-731

  Piper, Brian J ^a   Meyer, Jerrold S ^a  

^a Department of Obstetrics   (United States)

Author keywords

Adolescence; Behavior; Ecstasy; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PAROXETINE; SEROTONIN TRANSPORTER;

ADOLESCENT; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; HIPPOCAMPUS; ISOTOPE LABELING; MALE; MAZE TEST; MOBILIZATION; NEOCORTEX; NONHUMAN; OPEN FIELD TEST; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

AGE FACTORS; ANIMALS; ANXIETY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MEMORY DISORDERS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE TISSUE PROTEINS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

ANIMALIA;

EID: 10044258731     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.10.001     Document Type: Article

References (47)

1. 3H]-paroxetine-labeled serotonin uptake sites J. Pharmacol. Exp. Ther. 242 1987 911 916
2. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
3. H.W. Broening, L.L. Morford, S.L. Inman-Wood, M. Fukumura, and C.V. Vorhees 3,4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development J. Neurosci. 21 2001 3228 3235
4. E.J. Bull, P.H. Hutson, and K.C. Fone Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity Neuropharmacology 46 2004 202 210
5. S. Caccia, M. Ballabio, G. Guiso, M. Rocchetti, and S. Garattini Species differences in the kinetics and metabolism of fenfluramine isomers Arch. Int. Pharmacodyn. Ther. 258 1982 15 28
6. W.R. Chappell, and J. Mordenti Extrapolation of toxicological and pharmacological data from animals to humans Adv. Drug Res. 20 1991 1 116
7. J.C. Chen, G. Turiak, J. Galler, and L. Volicer Postnatal changes of brain monoamine levels in prenatally malnourished and control rats Int. J. Dev. Neurosci. 15 1997 257 263
8. W.L. Chiou, G. Robbie, S.M. Chung, T.C. Wu, and C. Ma Correlation of plasma clearance of 54 extensively metabolized drugs between humans and rats: mean allometric coefficient of 0.66 Pharm. Res. 15 1998 1474 1479
9. J. Cohen Statistical power analysis for the behavioral sciences 2nd ed. 1988 Lawrence Erlbaum Associates Hillsdale (NJ)
10. J.C. Crabbe, D. Wahlsten, and B.C. Dudek Genetics of mouse behavior: interactions with laboratory environment Science 284 1999 1670 1672
11. Dance Safe, 2004. URL: http://www.dancesafe.org/labtesting/pill-display. php?&limit=25&offset=125. Accessed 6/23/04.
12. A. Ennaceur, and J. Delacour A new one-trial test for neurobiological studies of memory in rats: 1. Behavioral data Behav. Brain Res. 31 1988 47 59
13. A. Ennaceur, and K. Meliani Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests Psychopharmacology 109 1992 321 330
14. K.T. Finnegan, G.A. Ricaurte, L.D. Ritchie, I. Irwin, S.J. Peroutka, and J.W. Langston Orally administered MDMA causes a long-term depletion of serotonin in rat brain Brain Res. 447 1988 141 144
15. C. Fischer, G. Hatzidimitriou, J. Wlos, J. Katz, and G. Ricaurte Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") J. Neurosci. 15 1995 5476 5485
16. K.C. Fone, S.R. Beckett, I.A. Topham, J. Swettenham, M. Ball, and L. Maddocks Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity Psychopharmacology 159 2002 437 444
17. C.H. Frith, L.W. Chang, D.L. Lattin, R.C. Walls, J. Hamm, and R. Doblin Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat Fundam. Appl. Toxicol. 9 1987 110 119
18. A.R. Green, and I.S. McGregor On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA Psychopharmacology 162 2002 448 450
19. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colodo The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol. Rev. 55 2003 463 508
20. C.G. Gurtman, K.C. Morley, K.M. Li, G.E. Hunt, and I.S. McGregor Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion Eur. J. Pharmacol. 446 2002 89 96
21. 3H]paroxetine binding to rat cortical membranes Eur. J. Pharmacol. 118 1985 107 114
22. Y. Kagamiishi, T. Yamamoto, and S. Watanabe Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotrophin-releasing factor Brain Res. 991 2003 212 221
23. P.A. Kelly, I.M. Ritchie, L. Quate, D.E. McBean, and H.J. Olverman Functional consequences of perinatal exposure to 3,4- methylenedioxymethamphetamine in rat brain Br. J. Pharmacol. 137 2002 963 970
24. K.G. Kjelstrup, F.A. Tuvnes, H.A. Steffenach, R. Murison, E.I. Moser, and M.B. Moser Reduced fear expression after lesions of the ventral hippocampus Proc. Natl. Acad. Sci. U. S. A. 99 2002 10825 10830
25. J. Lyles, and J.L. Cadet Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms Brain Res. Rev. 42 2003 155 168
26. N. MacInnes, S.L. Handley, and G.F. Harding Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms J. Psychopharmacol. 15 2001 181 186
27. J.E. Malberg, and L.S. Seiden Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat J. Neurosci. 18 1998 5086 5094
28. H.M. Marston, M.E. Reid, J.A. Lawrence, H.J. Olverman, and S.P. Butcher Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat Psychopharmacology 144 1999 67 76
29. I.S. McGregor, K.J. Clemens, G. Van Der Plasse, K.M. Li, G.E. Hunt, and F. Chen Increased anxiety 3 months after brief exposure to MDMA ('Ecstasy') in rats: association with altered 5-HT transporter and receptor density Neuropsychopharmacology 28 2003 1472 1484
30. I.S. McGregor, C.G. Gurtman, K.C. Morley, K.J. Clemens, A. Blokland, and K.M. Li Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes Psychopharmacology 168 2003 465 474
31. A.O. Mechan, P.M. Moran, M. Elliott, A.J. Young, M.H. Joseph, and R. Green A study of the effect of a single neurotoxic dose of 3,4- methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field Psychopharmacology 159 2002 167 175
32. J.S. Meyer, and S.F. Ali Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain Ann. N.Y. Acad. Sci. 965 2002 373 380
33. J.S. Meyer, M. Grande, K. Johnson, and S.F. Ali Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats Int. J. Dev. Neurosci. 22 2004 261 271
34. K.C. Morley, J.E. Gallate, G.E. Hunt, P.E. Mallet, and I.S. McGregor Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy") Eur. J. Pharmacol. 433 2001 91 99
35. S. Morley-Fletcher, M. Bianchi, G. Gerra, and G. Laviola Acute and carryover effects in mice of MDMA ("ecstasy") administration during periadolescence Eur. J. Pharmacol. 448 2002 31 38
36. E. O'Shea, R. Granados, B. Esteban, M.I. Colado, and A.R. Green The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy') Neuropharmacology 37 1998 919 926
37. A.C. Parrott Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research Hum. Psychopharmacol. 16 2001 557 577
38. A.C. Parrott, T. Buchanan, A.B. Scholey, T. Heffernan, J. Ling, and J. Rodgers Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users Hum. Psychopharmacol. 17 2002 309 312
39. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J. Neurosci. Methods 14 1985 149 167
40. G.A. Ricaurte, A.L. Markowska, G.L. Wenk, G. Hatzidimitriou, J. Wlos, and D.S. Olton 3,4-methylenedioxymethamphetamine, serotonin and memory J. Pharmacol. Exp. Ther. 266 1993 1097 1105
41. T.E. Robinson, E. Castaneda, and I.Q. Whishaw Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade Neuropsychopharmacology 8 1993 77 85
42. L.S. Seiden, W.L. Woolverton, S.A. Lorens, J.E. Williams, R.L. Corwin, and N. Hata Behavioral consequences of partial monoamine depletion in the CNS after methamphetamine-like drugs: the conflict between pharmacology and toxicology NIDA Res. Monogr. 136 1993 34 46
43. W. Slikker Jr., R.R. Holson, S.F. Ali, M.G. Kolta, M.G. Paule, and A.C. Scallet Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate Neurotoxicology 10 1989 529 542
44. L.P. Spear The adolescent brain and age-related behavioral manifestations Neurosci. Biobehav. Rev. 24 2000 417 463
45. J.E. Sprague, A.S. Preston, M. Leifheit, and B. Woodside Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning Physiol. Behav. 79 2003 281 287
46. Substance Abuse and Mental Health Services Administration, Results from the 2002 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NHSDA Series H-22, DHHS Publication No. SMA 03-3836. Rockville, MD, 2003.
47. G.S. Yacoubian Jr. Correlates of Ecstasy use among tenth graders surveyed through monitoring the future J. Psychoact. Drugs 34 2002 225 230